182 related articles for article (PubMed ID: 9285445)
1. Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumour.
Voltz RD; Posner JB; Dalmau J; Graus F
J Neurol Neurosurg Psychiatry; 1997 Aug; 63(2):133-6. PubMed ID: 9285445
[No Abstract] [Full Text] [Related]
2. Selection of recombinant anti-HuD Fab fragments from a phage display antibody library of a lung cancer patient with paraneoplastic encephalomyelitis.
Graus YF; Verschuuren JJ; Degenhardt A; van Breda Vriesman PJ; De Baets MH; Posner JB; Burton DR; Dalmau J
J Neuroimmunol; 1998 Mar; 82(2):200-9. PubMed ID: 9585817
[TBL] [Abstract][Full Text] [Related]
3. The anti-Hu syndrome: a model paraneoplastic disorder.
Posner JB
Recent Results Cancer Res; 1994; 135():77-90. PubMed ID: 8047700
[No Abstract] [Full Text] [Related]
4. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites.
Manley GT; Smitt PS; Dalmau J; Posner JB
Ann Neurol; 1995 Jul; 38(1):102-10. PubMed ID: 7541976
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer.
Dalmau J; Graus F; Cheung NK; Rosenblum MK; Ho A; Cañete A; Delattre JY; Thompson SJ; Posner JB
Cancer; 1995 Jan; 75(1):99-109. PubMed ID: 7804984
[TBL] [Abstract][Full Text] [Related]
6. Internalization of anti-Hu IgG is not Fc gamma receptor mediated.
Hormigo A; Ball C; Lieberman F
Neurology; 1996 Aug; 47(2):607-9. PubMed ID: 8757057
[No Abstract] [Full Text] [Related]
7. The expression of the Hu (paraneoplastic encephalomyelitis/sensory neuronopathy) antigen in human normal and tumor tissues.
Dalmau J; Furneaux HM; Cordon-Cardo C; Posner JB
Am J Pathol; 1992 Oct; 141(4):881-6. PubMed ID: 1415481
[TBL] [Abstract][Full Text] [Related]
8. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody.
Hersh B; Dalmau J; Dangond F; Gultekin S; Geller E; Wen PY
Neurology; 1994 Sep; 44(9):1754-5. PubMed ID: 7936310
[TBL] [Abstract][Full Text] [Related]
9. HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal.
Szabo A; Dalmau J; Manley G; Rosenfeld M; Wong E; Henson J; Posner JB; Furneaux HM
Cell; 1991 Oct; 67(2):325-33. PubMed ID: 1655278
[TBL] [Abstract][Full Text] [Related]
10. T-cell receptor analysis in anti-Hu associated paraneoplastic encephalomyelitis.
Voltz R; Dalmau J; Posner JB; Rosenfeld MR
Neurology; 1998 Oct; 51(4):1146-50. PubMed ID: 9781545
[TBL] [Abstract][Full Text] [Related]
11. [Abdominal complaints and neurological symptoms as an early sign of lung cancer: a manifestation of the anti-Hu syndrome].
Wymenga AN; Slebos DJ; van der Naalt J; van Putten JW; Peters FT
Ned Tijdschr Geneeskd; 2003 Mar; 147(13):616-9. PubMed ID: 12701397
[TBL] [Abstract][Full Text] [Related]
12. Changes in anti-HuD antibody titers in the long-term course in paraneoplastic sensory neuropathy.
Yagi Y; Inuzuka T; Takada K; Nakano R; Hozumi I; Yoshimoto H; Onodera O; Tanaka K; Sato S; Takahashi M
Eur Neurol; 1997; 37(2):122-3. PubMed ID: 9058069
[No Abstract] [Full Text] [Related]
13. Antibody recognition and RNA binding of a neuronal nuclear autoantigen associated with paraneoplastic neurological syndromes and small cell lung carcinoma.
Kumagai T; Kitagawa Y; Hirose G; Sakai K
J Neuroimmunol; 1999 Jan; 93(1-2):37-44. PubMed ID: 10378867
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation.
Vega F; Graus F; Chen QM; Poisson M; Schuller E; Delattre JY
Neurology; 1994 Nov; 44(11):2145-7. PubMed ID: 7969974
[TBL] [Abstract][Full Text] [Related]
15. Anti-Hu autoantibody associated sensory neuropathy/encephalomyelitis: a model of paraneoplastic syndrome.
Posner JB
Perspect Biol Med; 1995; 38(2):167-81. PubMed ID: 7899054
[No Abstract] [Full Text] [Related]
16. Limbic encephalitis and small cell lung cancer. Clinical and immunological features.
Alamowitch S; Graus F; Uchuya M; Reñé R; Bescansa E; Delattre JY
Brain; 1997 Jun; 120 ( Pt 6)():923-8. PubMed ID: 9217677
[TBL] [Abstract][Full Text] [Related]
17. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.
Graus F; Dalmou J; Reñé R; Tora M; Malats N; Verschuuren JJ; Cardenal F; Viñolas N; Garcia del Muro J; Vadell C; Mason WP; Rosell R; Posner JB; Real FX
J Clin Oncol; 1997 Aug; 15(8):2866-72. PubMed ID: 9256130
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic anti-Hu serum: studies on human tumor cell lines.
Verschuuren JJ; Dalmau J; Hoard R; Posner JB
J Neuroimmunol; 1997 Nov; 79(2):202-10. PubMed ID: 9394793
[TBL] [Abstract][Full Text] [Related]
19. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice.
Sillevis Smitt PA; Manley GT; Posner JB
Neurology; 1995 Oct; 45(10):1873-8. PubMed ID: 7477985
[TBL] [Abstract][Full Text] [Related]
20. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer.
Douglas CA; Ellershaw J
Palliat Med; 2003 Oct; 17(7):638-9. PubMed ID: 14594156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
